the medicare prescription drug price negotiation act of 2017 .
this bill amends title xviii (medicare) of the social security act to require the department of health and human services to negotiate with pharmaceutical manufacturers the prices that may be charged to pdp sponsors and ma organizations for covered part d drugs for part d eligible individuals who are enrolled under a prescription drug plan or under an ma-pd program.